Genesee Capital Advisors, LLC Bristol Myers Squibb CO Transaction History
Genesee Capital Advisors, LLC
- $208 Million
- Q4 2024
A detailed history of Genesee Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Genesee Capital Advisors, LLC holds 5,201 shares of BMY stock, worth $317,208. This represents 0.14% of its overall portfolio holdings.
Number of Shares
5,201
Previous 5,141
1.17%
Holding current value
$317,208
Previous $266,000
10.53%
% of portfolio
0.14%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,769Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.86 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.8 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...